Related Experiment Video
Updated: Jun 6, 2026
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Immunodiagnosis of chronic lymphocytic leukemia using immunological chips
N G Ovchinina1, A V Shishkin, E N Nikitin
1Izhevsk State Medical Academy, Russia. ntly.82@mail.ru
Insights
This study introduces immunological biochips for diagnosing chronic lymphocytic leukemia by detecting cellular surface antigens. Results show this novel method is comparable to established flow cytofluorometry techniques.
Area of Science:
- Immunology
- Hematology
- Biotechnology
Background:
- Chronic lymphocytic leukemia (CLL) diagnosis relies on immunophenotyping.
- Current methods like flow cytofluorometry are effective but can be resource-intensive.
Purpose of the Study:
- To evaluate the initial clinical application of immunological biochips for CLL diagnosis.
- To compare the diagnostic performance of biochips with standard flow cytofluorometry.
Main Methods:
- Utilized novel immunological biochips for the detection of cellular surface antigens.
- Employed immunomorphological analysis for diagnosis.
- Compared results against established flow cytofluorometry data.
Main Results:
- Demonstrated the feasibility of using immunological biochips in a clinical setting for CLL.
- Showcased comparable diagnostic accuracy between biochip detection and flow cytofluorometry.
- Highlighted the potential of biochips as an alternative diagnostic tool.
Conclusions:
- Immunological biochips represent a promising new technology for immunomorphological diagnosis of CLL.
- This method offers a viable alternative to flow cytofluorometry, potentially improving diagnostic accessibility.
Abstract:
The authors present their experience gained in the first clinical use of immunological biochips for detection of cellular surface antigens for immunomorphological diagnosis of chronic lymphocytic leukemia and compare the results of this method and flow cytofluorometry.
